low default risk,-0.473225
strong buy rating,0.407019
research analysts,0.283669
stake,-0.229924
chief executive officer,0.23709
hold rating,0.283669
InvestorPlace Broker Center,0.555736
average price target,-0.340863
Janus Capital Management,-0.229924
biopharmaceutical company,0.431223
personal trading style,0.598412
research-based biopharmaceutical company,0.642682
Stillwater Investment Management,0.219763
research note,0.414619
Gilead Sciences Inc.,0.555178
legal filing,-0.245224
average price,-0.277753
shares,-0.0224799
consensus estimate,0.394766
executive vice president,0.218254
concise daily summary,0.447788
Gilead Sciences,0.0453851
GILD,-0.320673
stock broker,0.245696
consensus rating,0.308546
rating,-0.10905
chronic hepatitis,-0.646567
quarter,-0.0101612
